Neuropace, Inc. · NASDAQ:NPCE

Orbimed Advisors LLC reported a 10.50% stake in Neuropace, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Orbimed Advisors LLC reported a 10.50% stake in Neuropace, Inc., 3,406,335 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
10.50%
Shares
3,406,335
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC10.50%3,406,335
OrbiMed Capital GP VI LLC10.50%3,406,335

Source

View original at SEC

Related